Evvivax is a Rome-based veterinary biotechnology company that gets its name from Engineered Veterinary Vectored Immunotherapy and Vaccines. The company researches and develops nucleic-acid based therapies, completes process development, provides industrial scale production and conducts clinical trials. Its technologies include genetic vaccines as well as in vivo electroporation.
CORONAVIRUS - Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine
February 4, 2020
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
September 19, 2019
Documentaries, videos and podcasts
Elephant in the Room Short Version
October 15, 2017
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.